background preloader

Antibioresistance aux Etats-Unis

Facebook Twitter

AASV 27/12/16 FDA Annual Summary Report on Antimicrobials Sold or Distributed in 2015 for Use in Food-Producing Animals. December 27, 2016 — The U.S.

AASV 27/12/16 FDA Annual Summary Report on Antimicrobials Sold or Distributed in 2015 for Use in Food-Producing Animals

Food and Drug Administration today published its annual report summarizing sales and distribution data for all antimicrobial drugs approved for use in food-producing animals. FDA 01/10/15 Présentation : Medically important antimicrobials in animal agriculture. CDC EID - Volume 20, Number 12—December 2014. Au sommaire: Effects of Knowledge, Attitudes, and Practices of Primary Care Providers on Antibiotic Selection, United States. Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA Suggested citation for this article Abstract Appropriate selection of antibiotic drugs is critical to optimize treatment of infections and limit the spread of antibiotic resistance.

CDC EID - Volume 20, Number 12—December 2014. Au sommaire: Effects of Knowledge, Attitudes, and Practices of Primary Care Providers on Antibiotic Selection, United States

To better inform public health efforts to improve prescribing of antibiotic drugs, we conducted in-depth interviews with 36 primary care providers in the United States (physicians, nurse practitioners, and physician assistants) to explore knowledge, attitudes, and self-reported practices regarding antibiotic drug resistance and antibiotic drug selection for common infections. NIH 07/04/14 NIH Funding Opportunity Focuses on Diagnostics for Hospital-Based Antibacterial-Resistant Infections - Awards to Total up to $12 Million in 2015.

​The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently announced a research funding opportunity to develop and/or produce diagnostics to quickly detect the key bacteria responsible for antibacterial-resistant infections in hospital settings.

NIH 07/04/14 NIH Funding Opportunity Focuses on Diagnostics for Hospital-Based Antibacterial-Resistant Infections - Awards to Total up to $12 Million in 2015

NIAID expects to fund 10-15 awards for a total of up to $12 million in 2015. The maximum length of each award is 5 years. Drug-resistant bacterial infections are a growing worldwide problem, causing significant illness, death and healthcare cost. Many of these infections are acquired in hospitals and other healthcare settings, where rapid and sensitive testing for specific types of bacteria are needed to enable physicians to determine the most effective treatments to improve individual patient outcomes and help curb bacterial resistance.

Investigators from academic organizations are eligible to submit proposals, but must establish a partnership with an industrial organization. CDC - Antimicrobial Resistance Threat Report 2013. Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content Get Email Updates To receive email updates about this page, enter your email address: CDCAntibiotic / Antimicrobial Resistance.

CDC - Antimicrobial Resistance Threat Report 2013.

CDC EID – MAI 2014 – Au sommaire: Factors Associated with Antimicrobial Drug Use in Medicaid Programs. Author affiliations: University of Pennsylvania, Philadelphia, Pennsylvania, USA Suggested citation for this article Abstract.

CDC EID – MAI 2014 – Au sommaire: Factors Associated with Antimicrobial Drug Use in Medicaid Programs

SAVEANTIBIOTICS via TWITTER 18/06/14 INFOGRAPHIE sur l'usage des antibiotiques aux Etats-Unis. CDC EID - Volume 21, Number 9—September 2015. Au sommaire: Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance ; Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.K.

CDC EID - Volume 21, Number 9—September 2015. Au sommaire: Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance ;

Fridkin, A.A. Cleveland, I. See); Minnesota Department of Public Health, St. Paul, Minnesota, USA (R. Lynfield) Suggested citation for this article Abstract Across the United States, antimicrobial drug–resistant infections affect a diverse population, and effective interventions require concerted efforts across various public health and clinical programs. The 1992 Institute of Medicine report Emerging Infections: Microbial Threats to Health in the United States describes the ability of microbes to adapt, the development of antimicrobial drug resistance, and the importance of recognizing and monitoring emerging microbial threats to human health (1). EIP as an Antimicrobial Drug Resistance Surveillance System EIP is grounded in performing active population-based and laboratory-based surveillance. Examples of Antimicrobial Drug Resistance Surveillance and Research in EIP Dr.

References. CDC 09/06/15 The 2013 NARMS Annual Human Isolates Report. Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options CDC Home CDC 24/7: Saving Lives.

CDC 09/06/15 The 2013 NARMS Annual Human Isolates Report

Protecting People.™ <div class="noscript"> Note: Javascript is disabled or is not supported by your browser. National Antimicrobial Resistance Monitoring System The 2013 NARMS Annual Human Isolates Report CDC NARMS tracks antimicrobial resistance in Salmonella and other enteric (intestinal) bacteria that may cause mild or severe diarrhea or bloodstream infection. About NARMS. NIAA via SWINECAST 23/04/15 Where Are We With Antibiotics In Agriculture? FDA via SWINECAST 23/04/15 Antimicrobial FDA Perspective. JDLE 25/09/13 L’antibiorésistance tue chaque année 23.000 Américains. Les dangers de l'antibiorésistance précisés Les bactéries antibiorésistantes infectent chaque année au moins 2 millions d’Américains et en tuent 23.000, révèlent les centres de contrôle et de prévention des maladies (CDC) dans leur rapport 2013 sur le sujet.

JDLE 25/09/13 L’antibiorésistance tue chaque année 23.000 Américains.

Outre son poids humain, l’antibiorésistance engendre un coût de santé annuel de 20 milliards de dollars (14,8 Md€), avec des pertes de productivité estimées à 35 Md$ (26 Md€). «Les antibiotiques constituent une ressource limitée, précieuse: plus nous les utilisons aujourd’hui, moins nous en aurons d’efficaces demain», rappelle Steve Solomon, directeur du bureau Antibiorésistance des CDC, dans un communiqué.

De plus en plus répandue, l’antibiorésistance est en effet liée à un usage abusif des antibiotiques. Chez l’homme, auquel 50% des antibiotiques sont prescrits sans réelle nécessité médicale, mais aussi dans les élevages qui, aux Etats-Unis, consomment 74% de ces médicaments. SCIENCES ET AVENIR 18/09/13 Les résistances aux antibiotiques tuent 23.000 américains par an. Aux USA, les empoisonnements par e-liquide augmentent.

SCIENCES ET AVENIR 18/09/13 Les résistances aux antibiotiques tuent 23.000 américains par an

Mais restent six fois moindres qu'avec les cigarettes classiques. En France, une étude est lancée... Fabriquer des tissus et des organes humains, couche après couche, selon une technique dérivée de l'impression 3D, c'est la promesse de la bio-impression. L'ex-ministre des sports et nouvelle secrétaire d'état au commerce est hospitalisée depuis vendredi. Prendre des suppléments de zinc permettrait de réduire la durée des symptômes du rhume de moitié. Une tétine-thermomètre pour suivre la température en continu de son enfant, sur son smartphone ou sa tablette. Disponible gratuitement, l'application calcule des programmes d'ajustement personnalisés aux différents fuseaux horaires en se basant sur la lumière. Questions à Jean-Louis Roumégas, député EE-LV de l’Hérault, auteur du rapport sur la stratégie européenne en matière de perturbateurs endocriniens.

Les Français consomment le double des quantités recommandées. CDC 23/04/13 ANTIBIOTIC RESISTANCE THREATS in the United States, 2013. CIDRAP 16/09/13 CDC: Antibiotic-resistant bugs sicken 2 million a year. The US Centers for Disease Control and Prevention (CDC) said today that antibiotic-resistant pathogens sicken 2 million Americans a year and listed the three most urgent threats as Clostridium difficile, carbapenem-resistant Enterobacteriaceae (CRE), and Neisseria gonorrhoeae.

CIDRAP 16/09/13 CDC: Antibiotic-resistant bugs sicken 2 million a year

The agency's first all-encompassing report on antibiotic disease threats spans 114 pages and ranks the pathogens in part to spur a multipronged effort to prioritize and battle the problems. Antibiotic-resistant microorganisms play a role in 23,000 deaths each year, the CDC said. At a media briefing today, CDC Director Tom Frieden, MD, MPH, said the landmark report provides a snapshot of the antibiotic-resistant organisms that have the biggest impact on human health. He said the numbers are very conservative estimates that don't take into account infections that occur outside hospitals, such as nursing homes and dialysis centers.

"The bottom line is stewardship," Frieden said. SCIENCES ET AVENIR 18/09/13 Les résistances aux antibiotiques tuent 23.000 américains par an. GAO - JUIN 2011 - ANTIBIOTIC RESISTANCE - Data Gaps Will Remain Despite HHS Taking Steps to Improve Monitoring. SOCIETY FOR HEALTHCARE EPIDEMIOLOGY OF AMERICA - Multi-Resistant Gram-Negative Bacteria. 2006 - Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006 Jane D. 2009 - The Interagency Task Force on Antimicrobial Resistance and A Public Health Action Plan to Combat Antimicrobial Resi. 2011 Annual Report Progress Report: 2011 Progress Towards Implementation of: A Public Health Action Plan to Combat Antimicrobial Resistance [PDF - 69 pages] Top 2009-2010 Annual Report Progress Report: 2009-2010 Progress Towards Implementation Of: Draft Document A Public Health Action Plan To Combat Antimicrobial Resistance [PDF - 346 KB] 2008 Annual Report.